Clinical Trial Update: INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) [Phase 3]

View source ↗

Summary

Phase 3 trial INCMGA00012 in combination with chemoradiation for stage III non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Incyte Corporation | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: WITHDRAWN